These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28152550)

  • 1. Novel 11β-hydroxysteroid dehydrogenase 1 inhibitors reduce cortisol levels in keratinocytes and improve dermal collagen content in human ex vivo skin after exposure to cortisone and UV.
    Boudon SM; Vuorinen A; Geotti-Bianchini P; Wandeler E; Kratschmar DV; Heidl M; Campiche R; Jackson E; Odermatt A
    PLoS One; 2017; 12(2):e0171079. PubMed ID: 28152550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of novel selective peptide inhibitors of 11β-hydroxysteroid dehydrogenase 1.
    Boudon S; Heidl M; Vuorinen A; Wandeler E; Campiche R; Odermatt A; Jackson E
    Bioorg Med Chem; 2018 Oct; 26(18):5128-5139. PubMed ID: 30245006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11β-hydroxysteroid dehydrogenase 1 specific inhibitor increased dermal collagen content and promotes fibroblast proliferation.
    Terao M; Tani M; Itoi S; Yoshimura T; Hamasaki T; Murota H; Katayama I
    PLoS One; 2014; 9(3):e93051. PubMed ID: 24667799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11β-Hydroxysteroid dehydrogenase 1 contributes to the pro-inflammatory response of keratinocytes.
    Itoi S; Terao M; Murota H; Katayama I
    Biochem Biophys Res Commun; 2013 Oct; 440(2):265-70. PubMed ID: 24055708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profiles of cortisol-inactivating enzyme, 11β-hydroxysteroid dehydrogenase-2, in human epidermal tumors and its role in keratinocyte proliferation.
    Terao M; Itoi S; Murota H; Katayama I
    Exp Dermatol; 2013 Feb; 22(2):98-101. PubMed ID: 23362866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Attenuates the Adverse Effects of Glucocorticoids on Dermal Papilla Cells.
    Lee SE; Lee EY; Kang SJ; Lee SH
    Yonsei Med J; 2017 Nov; 58(6):1204-1210. PubMed ID: 29047245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and structure-activity relationships of pentanedioic acid diamides as potent inhibitors of 11beta-hydroxysteroid dehydrogenase type I.
    Roche D; Carniato D; Leriche C; Lepifre F; Christmann-Franck S; Graedler U; Charon C; Bozec S; Doare L; Schmidlin F; Lecomte M; Valeur E
    Bioorg Med Chem Lett; 2009 May; 19(10):2674-8. PubMed ID: 19395260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evaluation of 11beta-hydroxysteroid dehydrogenase activity in the rabbit eye.
    Anderson S; Carreiro S; Quenzer T; Gale D; Xiang C; Gukasyan H; Lafontaine J; Cheng H; Krauss A; Prasanna G
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):215-22. PubMed ID: 19456256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel 11β-HSD1 inhibitors by combined ligand- and structure-based virtual screening.
    Lagos CF; Vecchiola A; Allende F; Fuentes CA; Tichauer JE; Valdivia C; Solari S; Campino C; Tapia-Castillo A; Baudrand R; Villarroel P; Cifuentes M; Owen GI; Carvajal CA; Fardella CE
    Mol Cell Endocrinol; 2014 Mar; 384(1-2):71-82. PubMed ID: 24447464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultraviolet radiation regulates cortisol activity in a waveband-dependent manner in human skin ex vivo.
    Skobowiat C; Sayre RM; Dowdy JC; Slominski AT
    Br J Dermatol; 2013 Mar; 168(3):595-601. PubMed ID: 23363016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and biological evaluation of adamantyl amide 11beta-HSD1 inhibitors.
    Webster SP; Ward P; Binnie M; Craigie E; McConnell KM; Sooy K; Vinter A; Seckl JR; Walker BR
    Bioorg Med Chem Lett; 2007 May; 17(10):2838-43. PubMed ID: 17350260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development and SAR of pyrrolidine carboxamide 11beta-HSD1 inhibitors.
    Cheng H; Hoffman J; Le P; Nair SK; Cripps S; Matthews J; Smith C; Yang M; Kupchinsky S; Dress K; Edwards M; Cole B; Walters E; Loh C; Ermolieff J; Fanjul A; Bhat GB; Herrera J; Pauly T; Hosea N; Paderes G; Rejto P
    Bioorg Med Chem Lett; 2010 May; 20(9):2897-902. PubMed ID: 20363126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.
    Jun YJ; Park SJ; Kim TH; Lee SH; Lee KJ; Hwang SM; Lee SH
    J Allergy Clin Immunol; 2014 Oct; 134(4):926-934.e6. PubMed ID: 24810847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol.
    Morris DJ; Latif SA; Hardy MP; Brem AS
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):161-8. PubMed ID: 17459698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local cortisol/corticosterone activation in skin physiology and pathology.
    Terao M; Katayama I
    J Dermatol Sci; 2016 Oct; 84(1):11-16. PubMed ID: 27431412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UVB induces epidermal 11β-hydroxysteroid dehydrogenase type 1 activity in vivo.
    Tiganescu A; Hupe M; Jiang YJ; Celli A; Uchida Y; Mauro TM; Bikle DD; Elias PM; Holleran WM
    Exp Dermatol; 2015 May; 24(5):370-6. PubMed ID: 25739654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of corticosteroids in skin physiology and therapeutic potential of an 11β-HSD1 inhibitor: A review.
    Hall L; Hart R
    Int J Dermatol; 2024 Apr; 63(4):443-454. PubMed ID: 38146184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes.
    Jang C; Obeyesekere VR; Dilley RJ; Krozowski Z; Inder WJ; Alford FP
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3314-20. PubMed ID: 17519316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo activity of 11β-hydroxysteroid dehydrogenase type 1 in man: effects of prednisolone and chenodesoxycholic acid.
    Diederich S; Quinkler M; Mai K; Schöneshöfer M; Baehr V; Pfeiffer A; Oelkers W; Eigendorff E
    Horm Metab Res; 2011 Jan; 43(1):66-71. PubMed ID: 20925019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Green tea and one of its constituents, Epigallocatechine-3-gallate, are potent inhibitors of human 11β-hydroxysteroid dehydrogenase type 1.
    Hintzpeter J; Stapelfeld C; Loerz C; Martin HJ; Maser E
    PLoS One; 2014; 9(1):e84468. PubMed ID: 24404164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.